X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare IPCA Labs with SHASUN PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs SHASUN PHARMA - Comparison Results

IPCA LABS    Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS SHASUN PHARMA IPCA LABS/
SHASUN PHARMA
 
P/E (TTM) x 27.5 123.9 22.2% View Chart
P/BV x 2.1 8.5 24.7% View Chart
Dividend Yield % 0.2 0.2 104.6%  

Financials

 IPCA LABS   SHASUN PHARMA
EQUITY SHARE DATA
    IPCA LABS
Mar-17
SHASUN PHARMA
Mar-14
IPCA LABS/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs64394 682.6%   
Low Rs50346 1,102.6%   
Sales per share (Unadj.) Rs254.4214.2 118.8%  
Earnings per share (Unadj.) Rs16.15.3 301.2%  
Cash flow per share (Unadj.) Rs29.815.8 188.2%  
Dividends per share (Unadj.) Rs1.001.00 100.0%  
Dividend yield (eoy) %0.21.4 12.2%  
Book value per share (Unadj.) Rs194.653.3 364.7%  
Shares outstanding (eoy) m126.2056.62 222.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.30.3 690.0%   
Avg P/E ratio x35.713.1 272.1%  
P/CF ratio (eoy) x19.24.4 435.5%  
Price / Book Value ratio x2.91.3 224.7%  
Dividend payout %6.218.7 33.2%   
Avg Mkt Cap Rs m72,3003,958 1,826.8%   
No. of employees `00013.3NA-   
Total wages/salary Rs m6,9602,164 321.7%   
Avg. sales/employee Rs Th2,413.5NM-  
Avg. wages/employee Rs Th523.2NM-  
Avg. net profit/employee Rs Th152.4NM-  
INCOME DATA
Net Sales Rs m32,10612,127 264.8%  
Other income Rs m226229 98.4%   
Total revenues Rs m32,33212,356 261.7%   
Gross profit Rs m4,4481,009 440.8%  
Depreciation Rs m1,730594 291.4%   
Interest Rs m241415 58.0%   
Profit before tax Rs m2,703230 1,176.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m675-73 -928.5%   
Profit after tax Rs m2,028302 671.3%  
Gross profit margin %13.98.3 166.5%  
Effective tax rate %25.0-31.7 -78.9%   
Net profit margin %6.32.5 253.5%  
BALANCE SHEET DATA
Current assets Rs m17,3406,884 251.9%   
Current liabilities Rs m9,5598,456 113.0%   
Net working cap to sales %24.2-13.0 -187.0%  
Current ratio x1.80.8 222.8%  
Inventory Days Days10062 162.8%  
Debtors Days Days57108 52.9%  
Net fixed assets Rs m20,7794,970 418.1%   
Share capital Rs m252113 222.8%   
"Free" reserves Rs m24,4992,875 852.2%   
Net worth Rs m24,5533,020 812.9%   
Long term debt Rs m3,5171,817 193.5%   
Total assets Rs m39,59513,347 296.7%  
Interest coverage x12.21.6 787.1%   
Debt to equity ratio x0.10.6 23.8%  
Sales to assets ratio x0.80.9 89.2%   
Return on assets %5.75.4 106.6%  
Return on equity %8.310.0 82.6%  
Return on capital %10.513.3 78.7%  
Exports to sales %48.646.4 104.9%   
Imports to sales %14.214.2 99.9%   
Exports (fob) Rs m15,6175,622 277.8%   
Imports (cif) Rs m4,5711,728 264.6%   
Fx inflow Rs m15,6175,843 267.3%   
Fx outflow Rs m5,8282,173 268.2%   
Net fx Rs m9,7903,669 266.8%   
CASH FLOW
From Operations Rs m2,764398 695.2%  
From Investments Rs m-1,432-1,635 87.6%  
From Financial Activity Rs m-1,5911,309 -121.6%  
Net Cashflow Rs m-25971 -363.5%  

Share Holding

Indian Promoters % 45.9 39.2 117.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 11.4 3.6 316.7%  
FIIs % 25.3 17.6 143.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.4 39.6 43.9%  
Shareholders   36,892 20,750 177.8%  
Pledged promoter(s) holding % 2.1 12.3 17.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   MERCK LTD  STERLING BIOTECH  JUBILANT LIFE SCIENCES  VENUS REMEDIES  PIRAMAL ENTERPRISES  

Compare IPCA LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Dr Reddy's & Lupin Surge over 2%(Closing)

Indian share markets continued to trade just above the dotted line in the afternoon session in a lackluster day of trading. At the closing bell, the BSE Sensex closed higher by 33 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


Aug 22, 2017 (Close)

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE IPCA LABS WITH

MARKET STATS